Carl L Berg MD FAASLD
Hepatology & Liver Transplantation
Professor of Medicine, Duke University School of Medicine
Join to view full profile
40 Duke Medicine CirDurham, NC 27710
Phone+1 919-684-8111
Dr. Berg is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Carl Berg is a gastroenterologist based in Durham, NC, specializing in hepatology and liver transplantation. He completed his medical education at Washington University in St. Louis School of Medicine, followed by a residency in internal medicine and a fellowship in gastroenterology. His expertise includes hepatic cirrhosis, transplant hepatology, and celiac disease. Dr. Berg has authored several publications focusing on liver transplantation, hepatitis, and hepatocellular carcinoma, with some of his work widely cited. He has been involved in clinical trials such as the Adult-to-Adult Living Donor Liver Transplantation Study and has received multiple accolades, including America's Top Doctors recognition.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 1989 - 1992
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1986 - 1989- WashU MedicineClass of 1986
Certifications & Licensure
NC State Medical License 2012 - 2024
VA State Medical License 1997 - 2024
WV State Medical License 2013 - 2014
MA State Medical License 1989 - 1998
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsImproved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy.Anjiya Shaikh, Tzu-Hao Lee, Peter Lymberopoulos, Jihane N Benhammou, Nicole Rich
Liver Transplantation. 2026-06-01 - 1 citationsHepatitis B Virus NAT Positive Donors in Non-Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Preventi...Patrick C K Tam, Goni Katz-Greenberg, Cameron R Wolfe, Kristen Lott, Carl L Berg
Clinical Transplantation. 2025-07-01 - 65 citationsAdvances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians.Dimitrios Moris, Alessandro Martinino, Sarah Schiltz, Peter J Allen, Andrew Barbas
CA. 2025-05-20
Press Mentions
Meet Debra Sudan, Master SurgeonJuly 14th, 2021- Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver TransplantationJuly 23rd, 2020
Duke Performs First Liver Transplant on Patient with HIVApril 4th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
